Optum Epidemiology, United States
Disclosure information not submitted.
Considerations for Negative Control Outcome Analyses in Vaccine Effectiveness Studies: Post-Hoc Analyses from an Adult Vaccine Effectiveness Study conducted within the FDA BEST Initiative
Tuesday, August 27, 20248:30 AM – 8:45 AM CEST
Effectiveness Over Time of a Complete Primary Series of the Original, Monovalent COVID-19 Vaccines Among Adults Aged 18-64 Years in the United States
Tuesday, August 27, 20249:15 AM – 9:30 AM CEST
